Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Zoetis Inc.

ZTS · NYSE · CIK 0001555280 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

68.6 / 100

3 buyers · 3 purchase transaction lines · $886.4K gross purchase

WHY THIS SIGNAL?

Buyer breadthModerate
Purchase sizeModerate
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+21.0 / 35
Purchase size+16.9 / 25
Role+20.0 / 20
Recency+0.7 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
MCCALLISTER MICHAEL BDirector
●○
DAMELIO FRANK ADirector
●○
Esch KevinExecutive Vice President
○○
FULLER JULIEExecutive Vice President
○○
Stetter MarkDirector
○
PARENT LOUISE MDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS3
PURCHASE CONCENTRATION57%Largest buyer: DAMELIO FRANK A · $501.3K
CLUSTER BUYING · 15D3 insidersPeak activity: 2026-05-11–2026-05-13

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

68.6 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 68.7
  2. 68.8
  3. 68.7
  4. 68.6
  5. 68.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

3Purchases
2Sales
79Other Form 4 lines
38SEC filings · 365 days
BUYING3 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+2.7%
3M
-0.8%
6M
-36.5%
12M
-47.9%

Volatility & liquidity

Volatility
32.4%
Beta
—
Avg daily value
USD 404.8M

Valuation

Market cap
USD 30.9B
P/E
11.6×

Fundamentals

Profit margin
28.2%
ROE
78.3%
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
18,424,459
Previous report
17,390,071
Avg daily volume
4,504,058
Days to cover
4.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-13DAMELIO FRANK APurchase (P)Common Stock6,650USD 75.39USD 501,344SEC filing ↗
2026-05-13Bisaro PaulPurchase (P)Common Stock2,000USD 75.88USD 151,760SEC filing ↗
2026-05-11MCCALLISTER MICHAEL BPurchase (P)Common Stock3,000USD 77.76USD 233,280SEC filing ↗
2021-02-19SCULLY ROBERT WPurchase (P)Common Stock7,590USD 164.68USD 1,249,931SEC filing ↗

Form 4 evidence

84 transaction lines in the latest 365-day window; 694 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30FULLER JULIEOption exercise / conversion (M)Common Stock799USD —USD —SEC filing ↗
2026-09-30FULLER JULIETax withholding (F)Common Stock274USD 69.83USD 19,133SEC filing ↗
2026-08-07DAMELIO FRANK AGift (G)Common Stock6,650USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30FULLER JULIEOption exercise / conversion (M)Common Stock799USD —USD —SEC filing ↗
2026-09-30FULLER JULIETax withholding (F)Common Stock274USD 69.83USD 19,133SEC filing ↗
2026-08-07DAMELIO FRANK AGift (G)Common Stock6,650USD 0.00USD 0SEC filing ↗
2026-06-10MCCALLISTER MICHAEL BGift (G)Common Stock1,209USD 0.00USD 0SEC filing ↗
2026-05-21Stetter MarkOption exercise / conversion (M)Common Stock1,572USD —USD —SEC filing ↗
2026-05-20PARENT LOUISE MOption exercise / conversion (M)Common Stock12,130USD —USD —SEC filing ↗
2026-05-13DAMELIO FRANK APurchase (P)Common Stock6,650USD 75.39USD 501,344SEC filing ↗
2026-05-13Bisaro PaulPurchase (P)Common Stock2,000USD 75.88USD 151,760SEC filing ↗
2026-05-11MCCALLISTER MICHAEL BPurchase (P)Common Stock3,000USD 77.76USD 233,280SEC filing ↗
2026-04-30Esch KevinOption exercise / conversion (M)Common Stock259USD —USD —SEC filing ↗
2026-04-30Esch KevinTax withholding (F)Common Stock75USD 114.97USD 8,623SEC filing ↗
2026-03-09Norden GregoryGift (G)Common Stock1,213USD 0.00USD 0SEC filing ↗
2026-02-19Sarbaugh KeithOption exercise / conversion (M)Common Stock386USD —USD —SEC filing ↗
2026-02-19Sarbaugh KeithTax withholding (F)Common Stock154USD 127.28USD 19,601SEC filing ↗
2026-02-19Reed Willie MOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗
2026-02-19PECK KRISTIN COption exercise / conversion (M)Common Stock7,354USD —USD —SEC filing ↗
2026-02-19PECK KRISTIN CTax withholding (F)Common Stock3,623USD 127.28USD 461,135SEC filing ↗
2026-02-19PARENT LOUISE MOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗
2026-02-19PARENT LOUISE MJ (J)Common Stock615USD 127.28USD 78,277SEC filing ↗
2026-02-19Norden GregoryOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗
2026-02-19Norden GregoryJ (J)Common Stock406USD 127.28USD 51,676SEC filing ↗
2026-02-19MCCALLISTER MICHAEL BOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗
2026-02-19MCCALLISTER MICHAEL BJ (J)Common Stock413USD 127.28USD 52,567SEC filing ↗
2026-02-19Leatherberry Antoinette ReneeOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗
2026-02-19Leatherberry Antoinette ReneeJ (J)Common Stock406USD 127.28USD 51,676SEC filing ↗
2026-02-19Lagano RoxanneOption exercise / conversion (M)Common Stock750USD —USD —SEC filing ↗
2026-02-19Lagano RoxanneTax withholding (F)Common Stock258USD 127.28USD 32,838SEC filing ↗
2026-02-19Joseph WettenyOption exercise / conversion (M)Common Stock2,050USD —USD —SEC filing ↗
2026-02-19Joseph WettenyTax withholding (F)Common Stock703USD 127.28USD 89,478SEC filing ↗
2026-02-19Hattersley GavinOption exercise / conversion (M)Common Stock1,619USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerZTS
CIK0001555280
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history694 transaction lines from 2020-01-15 to 2026-09-30
6 P purchase lines · 141 S sale lines · 547 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.